Received Mar 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | W027449 | — |
The patient did not report any adverse issues or side effects related to the administered dose; A HCP called to inquire about the validity and potency of an expired dose of PNEUMOVAX 23 (lot: W027449 expiration: 09/25/2024) that was inadvertently administered to a patient on 03/04/2025. The patient did not report any adverse issues or side eff; This spontaneous report was received from a pharmacist and refers to a(n) 53-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 04-Mar-2025, the patient was vaccinated with an expired dose of Pneumococcal Vaccine, Polyvalent (23-valent) injection, at a dose of 0.5 milliliters (mL), lot #W027449; which has been verified to be a valid, expiration date reported and upon internal validation established as 25-Sep-2024 (strength, dose number, route, anatomical site of administration and vaccination scheme frequency were not provided) for prophylaxis (Expired product administered). The vaccine had never been exposed to any temperature excursions. The HCP was provided with a "not supported" outcome per the Post Expiry Memo Vaccines and Biologics Administered. The patient did not report any adverse issues or side effects related to the administered (No adverse event).